These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19092453)

  • 1. Barriers to recruit female commercial sex workers for HIV vaccine trials: the Rio de Janeiro experience.
    Barroso PF; de Souza MB; do Lago RF; Pedrosa J; Yoshida CB; Faulhaber JC; Costa MD; Schechter M
    J Acquir Immune Defic Syndr; 2009 Jan; 50(1):116-7. PubMed ID: 19092453
    [No Abstract]   [Full Text] [Related]  

  • 2. Willingness to participate in HIV vaccine trials among a sample of men who have sex with men, with and without a history of commercial sex, Rio de Janeiro, Brazil.
    de Souza CT; Lowndes CM; Szwarcwald CL; Sutmöller F; Bastos FI
    AIDS Care; 2003 Aug; 15(4):539-48. PubMed ID: 14509868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus incidence and risk behavior in the 'Projeto Rio': results of the first 5 years of the Rio de Janeiro open cohort of homosexual and bisexual men, 1994-98.
    Sutmöller F; Penna TL; de Souza CT; Lambert J;
    Int J Infect Dis; 2002 Dec; 6(4):259-65. PubMed ID: 12718818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low HIV seroincidence among female commercial sex workers: a barrier for measuring HIV vaccine efficacy.
    Djomand G; Beyrer C; Buchbinder S
    J Acquir Immune Defic Syndr; 2008 Dec; 49(5):570. PubMed ID: 19202462
    [No Abstract]   [Full Text] [Related]  

  • 5. The Rio de Janeiro HIV vaccine site-II. Recruitment strategies and socio-demographic data of a HIV negative homosexual and bisexual male cohort in Rio de Janeiro, Brazil.
    Sutmoller F; de Souza CT; Monteiro JC; Penna T
    Mem Inst Oswaldo Cruz; 1997; 92(1):39-46. PubMed ID: 9302413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a high-risk heterosexual cohort for HIV vaccine efficacy trials in Rio de Janeiro, Brazil, using a sensitive/less-sensitive assay: an update.
    Barroso PF; Harrison LH; de Fátima Melo M; Batista SM; da Silva Bastos M; da Rosa Faulhaber JC; Moreira RI; do Lago RF; Schechter M
    J Acquir Immune Defic Syndr; 2004 Jul; 36(3):880-1. PubMed ID: 15213576
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV-1 infection among prostitutes in Rio de Janeiro, Brazil.
    De Meis C; De Vasconcellos AC; Linhares D; Andrada-Serpa MJ
    AIDS; 1991 Feb; 5(2):236-7. PubMed ID: 2031704
    [No Abstract]   [Full Text] [Related]  

  • 8. Feasibility and cohort development for HIV vaccine trials in Haiti.
    Deschamps MM; Johnson WD; Pape JW
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S231-3. PubMed ID: 7865308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Where does treatment optimism fit in? Examining factors associated with consistent condom use among people receiving antiretroviral treatment in Rio de Janeiro, Brazil.
    Hanif H; Bastos FI; Malta M; Bertoni N; Winch PJ; Kerrigan D
    AIDS Behav; 2014 Oct; 18(10):1945-54. PubMed ID: 24531794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV vaccine evaluation center in Rio de Janeiro, Brazil.
    Schechter M
    Vaccine; 2002 May; 20(15):1909-11. PubMed ID: 11983243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Willingness to participate in HIV vaccine trials among men who have sex with men in Rio de Janeiro, Brazil. Projeto Praça Onze Study Group.
    Périssé AR; Schechter M; Moreira RI; do Lago RF; Santoro-Lopes G; Harrison LH
    J Acquir Immune Defic Syndr; 2000 Dec; 25(5):459-63. PubMed ID: 11141246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scientific justification for the participation of children and adolescents in HIV-1 vaccine trials in South Africa.
    Jaspan HB; Gray GE; Robinson AK; Coovadia HM; Bekker LG
    S Afr Med J; 2005 Sep; 95(9):685-7. PubMed ID: 16327928
    [No Abstract]   [Full Text] [Related]  

  • 13. Report of the Fifth Brazilian Symposium on HIV/AIDS Research. Rio de Janeiro, RJ, Brazil. November 23-26, 2003.
    Bongertz V; Bou-Habib DC; Castello-Branco LR; Morgado MG
    Mem Inst Oswaldo Cruz; 2005 Feb; 100(1):67-71. PubMed ID: 15867967
    [No Abstract]   [Full Text] [Related]  

  • 14. Pilot study assessing HIV vaccine trial readiness among female sex workers, injection and non-injection drug users, and men who have sex with men in Spain.
    Etcheverry MF; de Lazzari E; Fuchs JD; Meroño M; Sierra E; Del Romero J; Evans JL; Mendez-Arancibia E; Jacques C; Rojas D; Segú M; Gatell JM; Joseph J
    AIDS Behav; 2010 Jun; 14(3):607-17. PubMed ID: 19037720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand.
    Celentano DD; Beyrer C; Natpratan C; Eiumtrakul S; Sussman L; Renzullo PO; Khamboonruang C; Nelson KE
    AIDS; 1995 Sep; 9(9):1079-83. PubMed ID: 8527082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience from HIV incidence cohorts in Thailand: implications for HIV vaccine efficacy trials.
    Weniger BG
    AIDS; 1994 Jul; 8(7):1007-10. PubMed ID: 7946086
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV preventive vaccine efficacy trials in the United States: an overview of target communities' concerns.
    Hodel D
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S255-6. PubMed ID: 7865312
    [No Abstract]   [Full Text] [Related]  

  • 18. Preparations for AIDS vaccine trials. Developing brief valid screening instruments for HIV-related sexual risk behavior among gay and bisexual men.
    McKirnan DJ; Doetsch J; Vanable P; Buchbinder S; Douglas JM; Judson F
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S285-8. PubMed ID: 7865320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral research contributions to planning and conducting HIV vaccine efficacy studies.
    Temoshok LR
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S277-80. PubMed ID: 7865318
    [No Abstract]   [Full Text] [Related]  

  • 20. HIV vaccines: the Uganda experience.
    Mugyenyi PN
    Vaccine; 2002 May; 20(15):1905-8. PubMed ID: 11983242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.